Connect with us

Hi, what are you looking for?

Smart Inhalers Market Size Growing at a CAGR of 25.5% from 2019 to 2027 says, The Insight Partners

According to The Insight Partners market research study titled ‘Smart Inhalers Market to 2027 – Global Analysis and Forecasts by Product, Disorder and End User.’ The Global Smart Inhalers Market is expected to reach US$ 8,033.21 Mn in 2027 from US$ 1,094.26 Mn in 2018. The market is estimated to grow with a CAGR of 25.5% from 2019-2027.

Smart inhalers are advanced form of inhalers that are digitally connected to apps on phone or tablet, which helps the physicians to manage patient’s medical condition more effectively. Smart inhalers use Bluetooth technology to identify the use of inhaler as well as remind patients to take their medication and gather data to help guide care. Other than the management of respiratory diseases, the device also sends an alert on smartphones when a patient enters a high pollen or highly polluted area, which helps a patient decide whether to avoid the environment. Smart inhalers have sensors, enabling the patients to automatically track how often the inhaler is being used by the patient, hence avoiding the chances of any human errors. The growth of the Smart Inhalers in healthcare market is attributed to the rising prevalence of asthma and COPD across the globe and growing geriatric population in regions such as Asia, Europe and North America are expected to boost are the key driving factors for the growth of the market in the forecast period.

Download sample PDF Copy of Smart Inhalers Market study at: https://www.theinsightpartners.com/sample/TIPRE00004568/

The major players operating in the smart inhalers market include GlaxoSmithKline plc, Adherium Ltd., Vectura Group plc, Novartis AG, Findair Sp. z o. o., Cohero Health, Crux Product Design Ltd, Teva Pharmaceuticals, 3M, and Amiko Digital Health Limited.

The market has witnessed various organic as well as inorganic developments during recent years in the smart inhaler market. During December 2018, GlaxoSmithKline plc and Pfizer Inc signed an agreement in order to combine their consumer health businesses into a new world-leading Joint Venture. This agreement has helped the companies to offer better services to its customers across the globe.

Global smart inhalers market, based on the product, was segmented as, nebulizers and inhalers. In 2018, the inhalers held the largest share of the market, by product. In addition, the segment is also anticipated to grow at a significant rate during the forecast period. Inhalers are widely used in respiratory disorders such as asthma and COPD. They are available in various forms such as manually-actuated pressurized metered-dose inhalers, breath-actuated pressurized metered-dose inhalers, dry powder inhalers, and mist inhalers. The use of the type of inhaler highly depends on the intensity of the respiratory disorder and the need for its diagnosis.

Inquiry for Discount on smart inhalers market at: https://www.theinsightpartners.com/discount/TIPRE00004568/

The market for smart inhalers is expected to grow, owing to factors such as increasing levels of air pollution as well as the rise in the smoking habits, rising prevalence of asthma and COPD across the globe and growing geriatric population. In addition, growth in the global healthcare market and increasing usage of smartphones, tablets & pads are likely to have a positive impact on the growth of the market in the coming years.

The rise in air pollution levels has been a matter of rising concern in developed as well as developing economies. As per data published by the World Health Organization (WHO) released during May 2018, 9 out of 10 individuals are believed to breathe air containing high levels of pollutants. Data published by WHO reveals that approximately 7 million people die every year due to exposure to fine particles present in polluted air, which penetrate deep into lungs and the cardiovascular system. This leads to various diseases such as lung cancer, pneumonia, chronic obstructive pulmonary diseases and respiratory infections, among others. Studies reveal, above 90% of air pollution-related deaths worldwide occur in low- and middle-income countries, especially in Asian and African countries, followed by low- and middleincome countries of the Eastern Mediterranean, European and the American regions. For instance, in Brazil, there has been a rising concern regarding the air pollution levels. Air pollution kills about 49,000 Brazilians every year. Out of which around 25,000 deaths are caused due to outdoor pollution, whereas 24,000 deaths are a result of indoor pollution due to cooking using wood or other solid fuels. Deaths due to both outdoor and indoor air pollution represents approximately one in every 26 deaths from all the causes of death in Brazil, making it the ninth largest mortality risk in the country.

The report segments the global smart inhalers market as follows:

Global Smart Inhalers Market – By Product

Inhalers
Nebulizers

Global Smart Inhalers Market – By Disorder

Asthma
Chronic Obstructive Pulmonary Disease (COPD)

Global Smart Inhalers Market – By End User

Home-Care Settings
Hospitals & Clinics

Interested in Purchasing Smart Inhalers Market Report? Click here @ https://www.theinsightpartners.com/buy/TIPRE00004568/

About Us:

The Insight Partners is a one stop industry research provider of actionable intelligence. We help our clients in getting solutions to their research requirements through our syndicated and consulting research services. We are a specialist in Technology, Healthcare, Manufacturing, Automotive and Defense, Food & beverage, Chemical and Materials, Semiconductors etc.

Contact Us:

Call: +1-646-491-9876

Email: sales@theinsightpartners.com

 

 

Written By

You may also like:

Business

Catherine Berthet (L) and Naoise Ryan (R) join relatives of people killed in the Ethiopian Airlines Flight 302 Boeing 737 MAX crash at a...

Tech & Science

Microsoft and Google drubbed quarterly earnings expectations.

Tech & Science

The groundbreaking initiative aims to provide job training and confidence to people with autism.

Business

There is no statutory immunity. There never was any immunity. Move on.